Use of the Patient Benefit Index to monitor treatment of chronic spontaneous urticaria with omalizumab

4 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Dermatologic Therapy (Online)
Vol/bind	32
Udgave nummer	3
Sider (fra-til)	e12902
ISSN	1529-8019
DOI	https://doi.org/10.1111/dth.12902
Status	Udgivet - maj 2019

Adgang til dokumentet

@article{525ed85c5fb540bcab740f82a258029f,

title = "Use of the Patient Benefit Index to monitor treatment of chronic spontaneous urticaria with omalizumab",

keywords = "Adult, Chronic Urticaria/drug therapy, Female, Humans, Male, Omalizumab/therapeutic use, Patient Reported Outcome Measures",

author = "Chodziuk, {Astrid C} and Ghazanfar, {Misbah N} and Thomsen, {Simon F}",

year = "2019",

month = may,

doi = "10.1111/dth.12902",

language = "English",

volume = "32",

pages = "e12902",

journal = "Dermatologic Therapy (Online)",

issn = "1529-8019",

publisher = "Wiley-Blackwell Publishing, Inc",

number = "3",

}

TY - JOUR

T1 - Use of the Patient Benefit Index to monitor treatment of chronic spontaneous urticaria with omalizumab

AU - Chodziuk, Astrid C

AU - Ghazanfar, Misbah N

AU - Thomsen, Simon F

PY - 2019/5

Y1 - 2019/5

KW - Adult

KW - Chronic Urticaria/drug therapy

KW - Female

KW - Humans

KW - Male

KW - Omalizumab/therapeutic use

KW - Patient Reported Outcome Measures

U2 - 10.1111/dth.12902

DO - 10.1111/dth.12902

M3 - Comment/debate

C2 - 30964569

SN - 1529-8019

VL - 32

SP - e12902

JO - Dermatologic Therapy (Online)

JF - Dermatologic Therapy (Online)

IS - 3

ER -